Clinical efficacy and safety of PD-1 inhibitor combined with apatinib in the third line treatment of HER2-negative advanced gastric cancer
"<b>Objective</b> To explore the efficacy and safety of programmed cell death receptor 1 (PD-1) inhibitor combined with apatinib in the treatment of human epidermal growth factor receptor2 (HER2)-negative advanced gastric cancer after second-line treatment failure. <b>Method...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
The Editorial Department of Chinese Journal of Clinical Research
2025-01-01
|
| Series: | Zhongguo linchuang yanjiu |
| Subjects: | |
| Online Access: | http://zglcyj.ijournals.cn/zglcyj/ch/reader/create_pdf.aspx?file_no=20250109&year_id=2025&quarter_id=1&falg=1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|